TREATMENT OF ADVANCED PROSTATIC CANCER WITH LHRH ANALOGUE ICI 118630: CLINICAL RESPONSE AND HORMONAL MECHANISMS
- 1 August 1983
- journal article
- research article
- Published by Elsevier in The Lancet
- Vol. 322 (8347), 415-419
- https://doi.org/10.1016/s0140-6736(83)90387-2
Abstract
No abstract availableThis publication has 15 references indexed in Scilit:
- Tumor growth inhibition in patients with prostatic carcinoma treated with luteinizing hormone-releasing hormone agonists.Proceedings of the National Academy of Sciences, 1982
- Gonadotropin-Releasing Hormone Receptors: Characterization, Physiological Regulation, and Relationship to Reproductive FunctionEndocrine Reviews, 1981
- LH‐RH Agonists and AntagonistsInternational Journal of Gynecology & Obstetrics, 1980
- INHIBITORY EFFECTS ON GONADOTROPHIN SECRETION AND GONADAL FUNCTION IN MEN DURING CHRONIC TREATMENT WITH A POTENT STIMULATORY LUTEINIZING HORMONE-RELEASING HORMONE ANALOGUEActa Endocrinologica, 1979
- Direct Inhibition of Leydig Cell Function by Estradiol*Journal of Clinical Endocrinology & Metabolism, 1978
- Synthesis and biological activity of highly active .alpha.-aza analogs of luliberinJournal of Medicinal Chemistry, 1978
- A simple method for the assay of eight steroids in small volumes of plasmaSteroids, 1976
- PITUITARY FUNCTION AFTER TREATMENT OF INTRACRANIAL TUMOURS IN CHILDRENThe Lancet, 1975
- Experience in the Treatment of Prostatic Carcinoma with Cyproterone AcetateJournal of Urology, 1973
- Mechanism of Androgenic Action: Effect of Specific Intracellular InhibitorsJournal of Urology, 1971